CE Earnings

CE reported its FY2025Q4 earnings on 2026-02-17, showcasing a revenue of 0.00 against an estimate of 2.00B, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.89 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CE's FY2025Q4 earnings announcement on 2026-02-17, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, CE's stock price tends to shift by an average of +2.64% in the 10 days leading up to earnings and -6.49% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate CE’s annual revenue to reach 2.00B, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -1.43% and EPS estimates Revise Downward by -3.76% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -1.43%, while EPS estimates moved Revise Downward by -3.76% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CE's stock price typically moves by +2.64% in the 10 days before its earnings and -6.49% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.00 and revenue of 2.00B.

The earnings call highlights strong financial metrics, optimistic guidance, and strategic initiatives like product expansion and operational efficiencies. The Q&A section addresses concerns effectively, with no major risks identified. Positive aspects include high demand in key sectors, margin improvements, and proactive inventory management. While there are some uncertainties, such as the impact of Anti-involution in China, overall sentiment remains positive. The company's strategic initiatives and financial outlook suggest a likely stock price increase over the next two weeks.